AstraZeneca Aktie
155,00
EUR
+0,55
EUR
+0,36
%
144,77
CHF
-0,56
CHF
-0,39
%
Werbung
AstraZeneca Aktie Analyse
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 28.02.19 | AstraZeneca Reduce | HSBC | |
| 26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca overweight | Barclays Capital | |
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung